Detalhe da pesquisa
1.
Feasibility of tracking invasive Escherichia coli disease among older adults in a community setting: A prospective observational study.
Eur J Clin Microbiol Infect Dis
; 43(3): 541-550, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38236365
2.
Clinical presentation and antimicrobial resistance of invasive Escherichia coli disease in hospitalized older adults: a prospective multinational observational study.
Infection
; 2024 Jan 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-38267801
3.
Safety and Immunogenicity of Ad26-Vectored HIV Vaccine With Mosaic Immunogens and a Novel Mosaic Envelope Protein in HIV-Uninfected Adults: A Phase 1/2a Study.
J Infect Dis
; 227(8): 939-950, 2023 04 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-36348617
4.
Clinical burden of invasive Escherichia coli disease among older adult patients treated in hospitals in the United States.
BMC Infect Dis
; 23(1): 550, 2023 Aug 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-37608247
5.
Performance characteristics of code-based algorithms to identify urinary tract infections in large United States administrative claims databases.
Pharmacoepidemiol Drug Saf
; 31(9): 953-962, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35790044
6.
Development and performance characteristics of novel code-based algorithms to identify invasive Escherichia coli disease.
Pharmacoepidemiol Drug Saf
; 31(9): 983-991, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35753071
7.
Central Nervous System Safety During Brief Analytic Treatment Interruption of Antiretroviral Therapy Within 4 Human Immunodeficiency Virus Remission Trials: An Observational Study in Acutely Treated People Living With Human Immunodeficiency Virus.
Clin Infect Dis
; 73(7): e1885-e1892, 2021 10 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-32916708
8.
First-in-Human Randomized, Controlled Trial of Mosaic HIV-1 Immunogens Delivered via a Modified Vaccinia Ankara Vector.
J Infect Dis
; 218(4): 633-644, 2018 07 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-29669026
9.
Immunogenicity of 2 therapeutic mosaic HIV-1 vaccine strategies in individuals with HIV-1 on antiretroviral therapy.
NPJ Vaccines
; 9(1): 89, 2024 May 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-38782902
10.
Safety, Reactogenicity, Immunogenicity, and Dose Selection of 10-Valent Extraintestinal Pathogenic Escherichia coli Bioconjugate Vaccine (VAC52416) in Adults Aged 60-85 Years in a Randomized, Multicenter, Interventional, First-in-Human, Phase 1/2a Study.
Open Forum Infect Dis
; 10(8): ofad417, 2023 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-37608916
11.
Epidemiology, Clinical Features, and Antimicrobial Resistance of Invasive Escherichia Coli Disease in Patients Admitted in Tertiary Care Hospitals.
Open Forum Infect Dis
; 10(2): ofad026, 2023 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-36817744
12.
Safety and immunogenicity of two heterologous HIV vaccine regimens in healthy, HIV-uninfected adults (TRAVERSE): a randomised, parallel-group, placebo-controlled, double-blind, phase 1/2a study.
Lancet HIV
; 7(10): e688-e698, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-33010242
13.
Safety and immunogenicity of Ad26 and MVA vaccines in acutely treated HIV and effect on viral rebound after antiretroviral therapy interruption.
Nat Med
; 26(4): 498-501, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-32235883
14.
Comparative Efficacy, Safety and Immunogenicity of Hepavax-Gene TF and Engerix-B Recombinant Hepatitis B Vaccines in Neonates in China.
Pediatr Infect Dis J
; 36(1): 94-101, 2017 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27753794
15.
Immunogenicity and estimation of antibody persistence following vaccination with an inactivated virosomal hepatitis A vaccine in adults: A 20-year follow-up study.
Vaccine
; 35(10): 1448-1454, 2017 03 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-28190741
16.
Long-term Serologic Follow-up of Children Vaccinated with a Pediatric Formulation of Virosomal Hepatitis A Vaccine Administered With Routine Childhood Vaccines at 12-15 Months of Age.
Pediatr Infect Dis J
; 35(7): e220-8, 2016 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-27093164
17.
The safety and immunogenicity of two hepatitis B vaccine formulations (thiomersal-free and thiomersal-containing) in healthy vietnamese infants: a phase III, prospective, single-blinded, randomized, controlled trial.
Pediatr Infect Dis J
; 34(1): 79-83, 2015 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-25036048
18.
Long-term antibody persistence in children after vaccination with the pediatric formulation of an aluminum-free virosomal hepatitis A vaccine.
Pediatr Infect Dis J
; 34(4): e85-91, 2015 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-25389920
19.
Immunogenicity and safety of a pediatric dose of a virosomal hepatitis A vaccine in healthy children in India.
Hum Vaccin Immunother
; 10(7): 2089-97, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-25424821